Experiment 1054888

Details

PropertyValue
Pharmacology
Administration routeIV INFUSION
OrganismEmpty organism
CitationSESSA,C: D'INCALCI,M: LANDONI,F: COLOMOB,N: MANGIONI,C:. (1984). TENIPOSIDE IN REFRACTORY OVARIAN CANCER: A PHASE II STUDY.. 68(5)
Amount utilized
Compound isolated
DiseaseA PHASE II STUDY. DOSES GIVEN BY 1 HR INFUSION,ON DAY 1 100MG/M2,DAY 8 150MG/M2 AND DAY 22 120MG/M2. 23 PATIENTS WERE TREATED FOR REFRACTORY OVARIAN CANCER. SIDE EFFECTS INCLUDE LEUKOPENIA,NAUSE AND VOMITING,AND ALOPECIA AFTER THE 3RD COURSE.
Dose amountVAR
Number1
Qualitative result.
AnimalHUMAN ADULT
Dose expressionDOSE
GenderFEMALE